Fujita, Tetsuo <br/><br/>
Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patients.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  May 2006 
 - 84-90 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0360-3016 
<br/><br/><label>Standard No.: </label>10.1016/j.ijrobp.2005.11.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acyclovir--analogs & derivatives<br/>Adenoviridae--genetics<br/>Aged<br/>Aged, 80 and over<br/>Androgen Antagonists--therapeutic use<br/>Antiviral Agents--therapeutic use<br/>CD4-Positive T-Lymphocytes--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Combined Modality Therapy--methods<br/>Genetic Therapy--methods<br/>Humans<br/>Immunity, Cellular<br/>Killer Cells, Natural--immunology<br/>Male<br/>Middle Aged<br/>Prostatic Neoplasms--immunology<br/>Radiotherapy, Intensity-Modulated<br/>Thymidine Kinase--administration & dosage<br/>Valacyclovir<br/>Valine--analogs & derivatives